Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis.

Anderson AS, Scully IL, Timofeyeva Y, Murphy E, McNeil LK, Mininni T, Nuñez L, Carriere M, Singer C, Dilts DA, Jansen KU.

J Infect Dis. 2012 Jun;205(11):1688-96. doi: 10.1093/infdis/jis272. Epub 2012 Apr 2.

2.

Challenges for the evaluation of Staphylococcus aureus protein based vaccines: monitoring antigenic diversity.

Murphy E, Lin SL, Nunez L, Andrew L, Fink PS, Dilts DA, Hoiseth SK, Jansen KU, Anderson AS.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:51-9. Epub 2011 Jan 1.

PMID:
21245656
3.

NMR dynamics and antibody recognition of the meningococcal lipidated outer membrane protein LP2086 in micellar solution.

Mascioni A, Moy FJ, McNeil LK, Murphy E, Bentley BE, Camarda R, Dilts DA, Fink PS, Gusarova V, Hoiseth SK, Malakian K, Mininni T, Novikova E, Lin S, Sigethy S, Zlotnick GW, Tsao DH.

Biochim Biophys Acta. 2010 Feb;1798(2):87-93. doi: 10.1016/j.bbamem.2009.09.021. Epub 2009 Oct 14.

4.

Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis.

Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, Fink PS, Ambrose K, Borrow R, Findlow J, Taha MK, Deghmane AE, Kriz P, Musilek M, Kalmusova J, Caugant DA, Alvestad T, Mayer LW, Sacchi CT, Wang X, Martin D, von Gottberg A, du Plessis M, Klugman KP, Anderson AS, Jansen KU, Zlotnick GW, Hoiseth SK.

J Infect Dis. 2009 Aug 1;200(3):379-89. doi: 10.1086/600141.

PMID:
19534597
5.

Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: implications for vaccine design.

Nanra JS, Timofeyeva Y, Buitrago SM, Sellman BR, Dilts DA, Fink P, Nunez L, Hagen M, Matsuka YV, Mininni T, Zhu D, Pavliak V, Green BA, Jansen KU, Anderson AS.

Vaccine. 2009 May 26;27(25-26):3276-80. doi: 10.1016/j.vaccine.2009.01.062. Epub 2009 Feb 5.

PMID:
19200819
6.

Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086.

Mascioni A, Bentley BE, Camarda R, Dilts DA, Fink P, Gusarova V, Hoiseth SK, Jacob J, Lin SL, Malakian K, McNeil LK, Mininni T, Moy F, Murphy E, Novikova E, Sigethy S, Wen Y, Zlotnick GW, Tsao DH.

J Biol Chem. 2009 Mar 27;284(13):8738-46. doi: 10.1074/jbc.M808831200. Epub 2008 Dec 22.

7.

Polymorphism of the major surface epitope of the CopB outer membrane protein of Moraxella catarrhalis.

Liu DF, Xie X, Mastri MG, Fortuna-Nevin M, Colocillo C, Fletcher L, Dilts DA, McMichael JC, Baker SM.

FEMS Immunol Med Microbiol. 2006 Aug;47(3):343-50.

8.

Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.

Kirkham LA, Kerr AR, Douce GR, Paterson GK, Dilts DA, Liu DF, Mitchell TJ.

Infect Immun. 2006 Jan;74(1):586-93.

9.

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity.

Dilts DA, Riesenfeld-Orn I, Fulginiti JP, Ekwall E, Granert C, Nonenmacher J, Brey RN, Cryz SJ, Karlsson K, Bergman K, Thompson T, Hu B, Brückner AH, Lindberg AA.

Vaccine. 2000 Feb 14;18(15):1473-84.

PMID:
10618545
10.

Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae.

Matsuka YV, Dilts DA, Hoiseth S, Arumugham R.

J Protein Chem. 1998 Oct;17(7):719-28.

PMID:
9853688
11.

Oral delivery of antigens in live bacterial vectors.

Brey RN, Bixler GS, Fulginiti JP, Dilts DA, Sabara MI.

Adv Exp Med Biol. 1991;303:169-84. Review. No abstract available.

PMID:
1725232
12.

To cut casual absenteeism: tie benefits to hours worked.

Deitsch CR, Dilts DA.

Compens Rev. 1981;13(1):41-6. No abstract available.

PMID:
10249964

Supplemental Content

Loading ...
Support Center